Roche cuts jobs in Spain in response to price controls
- Roche will negotiate with unions in order to minimize the negative impact that the 100 job cuts will have on the workforce.
- A new organizational model is being implemented starting November 1.
- The overall restructuring plan places greater emphasis on teamwork, flexible decision-making, and increased individual responsibility, according to Roche spokespeople.
In addition to implementing a major shift in corporate culture at Roche’s Spanish division, the company has chosen to cut staff in order to adjust to the reality of continued price controls and downward pressure on costs.
In 2013, Spain’s drug spending dropped by 6.1% to $12 billion.The Spanish Health Minister, Ana Mato, also lowered reference prices for certain generics while concurrently reducing the price that the Spanish government pays for medications and medical devices.
- Pharma Times Roche to slash Spanish jobs in response to price controls
- Pharma Times Spanish market on the rise